Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL707326 | 0.89 | TSHR (0.41) | TSHRALDH1A1 | |
| SCHEMBL1088246 | 0.89 | TSHR (0.31) | TSHR | |
| SCHEMBL1087843 | 0.89 | TSHR (0.31) | TSHR | |
| SCHEMBL1087095 | 0.89 | TSHR (0.31) | TSHR | |
| SCHEMBL475861 | 0.72 | TSHR (0.41) | TSHRALDH1A1 | |
| SCHEMBL509444 | 0.72 | TSHR (0.41) | TSHRALDH1A1 | |
| SCHEMBL3293211 | 0.71 | TSHR (0.37) | TSHRALDH1A1 | |
| SCHEMBL3298710 | 0.71 | TSHR (0.37) | TSHRALDH1A1 | |
| SCHEMBL476054 | 0.70 | TSHR (0.39) | TSHRALDH1A1 | |
| SCHEMBL3209259 | 0.70 | TSHR (0.35) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1608716-B1 | PROCESS FOR THE PREPARATION OF POLY(SILYL ESTER)S, AND THEIR USES | SIGMAKALON B V (NL) | 2011-11-16 | — | — | EP | claimed |
| US-20110263605-A1 | Azabicyclo[2.2.1]Heptane Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands | BRISTOL-MYERS SQUIBB COMPANY | 2011-10-27 | — | — | US | claimed |
| EP-1608716-B8 | PROCESS FOR THE PREPARATION OF POLY(SILYL ESTER)S, AND THEIR USES | PPG BV (NL) | 2012-03-07 | — | — | EP | disclosed |
| EP-1608716-B1 | PROCESS FOR THE PREPARATION OF POLY(SILYL ESTER)S, AND THEIR USES | SIGMAKALON B V (NL) | 2011-11-16 | — | — | EP | disclosed |
| US-20110263605-A1 | Azabicyclo[2.2.1]Heptane Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands | BRISTOL-MYERS SQUIBB COMPANY | 2011-10-27 | — | — | US | disclosed |
| US-7902313-B2 | Process for the preparation of poly(silyl ester)s, and their uses | SIGMAKALON B.V. (NL) | 2011-03-08 | — | — | US | disclosed |
| US-20060241240-A1 | Process for the preparation of poly(silyl ester)s, and their uses | SIGMA KALON B.V. (NL) | 2006-10-26 | — | — | US | disclosed |
| EP-1608716-A1 | PROCESS FOR THE PREPARATION OF POLY(SILYL ESTER)S, AND THEIR USES | SigmaKalon B.V. (NL) | 2005-12-28 | — | — | EP | disclosed |
| WO-2004085560-A1 | PROCESS FOR THE PREPARATION OF POLY(SILYL ESTER)S, AND THEIR USES | SIGMAKALON B.V. (NL) | 2004-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263605-A1 | Azabicyclo[2.2.1]Heptane Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands | CHRNA7, CHRNA2, CHRNA5 | TSHR 329/4885ALDH1A1 531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.